Website intended for a NZ health professional readership
We are on our summer break and the editorial office is closed until 18 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists have selected articles from our 2020 news and clinical archives, The Conversation and other publications with which we share content. Please note the comment function has been turned off while we are away. Happy reading.
From Martin Johnston: I chose this article because it is a reminder of the uncertainty we all faced as New Zealand entered its national pandemic lockdown in March. Michael Baker reflects on how he was overjoyed at the sudden switch in policy to eradication of the novel coronavirus
Pharmacist prescribers Linda Bryant and Leanne Te Karu discuss positive polypharmacy for heart failure. Current evidence shows the intensive implementation of four medications offers the greatest benefit to most patients with heart failure, with significant reductions in cardiovascular mortality, heart failure hospitalisations and all-cause mortality
